Neuralink is a company that makes brain implants to help people with disabilities and to connect humans and machines. The company is led by Elon Musk, who is also the CEO of Tesla and SpaceX. Recently, Neuralink did a successful test on a human, and this made the company more valuable. Some employees of Neuralink want to sell their shares of the company, which are not publicly traded, and they need special permission to do so. The company might help them by buying back their shares in a tender offer. This is important because Neuralink is competing with other companies that also work on brain-computer interfaces. Read from source...

- The article title is misleading and clickbait: "Elon Musk's Brain Chip Company Neuralink Employees Eye Stock Sale After Valuation Surge: Report"
- The article does not provide any evidence or source for the claim that employees are eyeing for a stock sale. It only cites an unnamed "one person briefed on the matter" and a Reuters report that does not seem to exist.
- The article relies on secondary market trades to estimate Neuralink's valuation, which is not a reliable or representative source of information for a private company. It also compares the valuation to SpaceX and xAI, which are not directly comparable entities.
- The article mentions Elon Musk's past practice of creating scarcity of shares in his startups, implying that this is a negative or controversial fact, rather than a valid reason for the high demand and premium for Neuralink shares.
- The article does not provide any context or analysis of the recent human trial results, the potential market size, the competitive landscape, or the ethical and regulatory challenges of brain-computer interface technology. It only briefly mentions them as "background" information.
- The article ends with a shameless plug for Benzinga's services, which is irrelevant and inappropriate for a news article.